Amedisys, Inc. (AMED), one of America's leading home health, hospice and personal care companies, today announced that Paul B. Kusserow, President and Chief Executive Officer will present at the BofA Securities 2020 Virtual Health Care Conference on Tuesday, May 12, 2020. To access a live webcast of the Amedisys presentation, please log on through our website at http://investors.amedisys.com. Amedisys, Inc. is a leading healthcare at home company delivering personalized home health, hospice and personal care.
The best health care stocks to watch have several commonalities including a streak of earnings growth. It's important to keep tabs on high-ranking health care stocks with strong metrics.
Amedisys (AMED) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Amedisys, Inc. (AMED), one of the nation’s leading home healthcare, hospice and personal care companies, celebrates National Nurses Month by honoring more than 8,000 nurses who call the company home. Traditionally, National Nurses Week begins each year on May 6 and ends on May 12, Florence Nightingale’s birthday. With the World Health Organization declaring 2020 as the Year of the Nurse and Midwife, this celebration has been extended to the entire month.
Q1 2020 Amedisys Inc Earnings Call
Amedisys (NASDAQ:AMED) shares have had a really impressive month, gaining 45%, after some slippage. Looking back a bit...
Amedisys, a nursing home care provider, broke out over a 202.86 entry after clearing an early entry at 190.50 last week. This was an outside day for a long-term leader.
Thursday's market rally defied soaring jobless claims and coronavirus cases. Tesla leapt as Q1 deliveries beat lowered views. Dexcom and Nvidia have brand-new bases.
DEEP DIVE The COVID-19 pandemic has accelerated some health-care trends while opening people’s eyes to others that now seem obvious. Analysts at investment bank Jefferies have listed stocks of companies they argue are likely winners and losers from those trends.
Is (AMED) Outperforming Other Medical Stocks This Year?
BATON ROUGE, La., May 06, 2020 -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period ended March 31, 2020. Three-Month Periods Ended.
Amedisys, Inc. (AMED), announced today that it will report results for the first quarter ended March 31, 2020, after the market closes on May 6, 2020. The Company will host an investor conference call to discuss these results at 11:00 a.m. ET on May 7, 2020. To participate on the conference call, please call a few minutes before 11:00 a.m. ET to either (877) 524-8416 (Toll-Free) or (412) 902-1028 (Toll).
Amedisys, Inc. (AMED), one of America's leading home health, hospice and personal care companies, today announced that Paul B. Kusserow, President and Chief Executive Officer will present at RBC Capital Markets 2020 Global Healthcare Conference on Tuesday, May 19, 2020. To access a live webcast of the Amedisys presentation, please log on through our website at http://investors.amedisys.com. Amedisys, Inc. is a leading healthcare at home company delivering personalized home health, hospice and personal care.
Amedisys (AMED) has been upgraded to a Zacks Rank 2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Amedisys, Inc...
Amedisys, Inc. (NASDAQ:AMED), which is in the healthcare business, and is based in United States, received a lot of...
Amedisys (AMED) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Amedisys (AMED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Amedisys, Inc. (AMED), one of America's leading home health, hospice and personal care companies, today announced that Paul B. Kusserow, President and Chief Executive Officer will present at the UBS Global Healthcare Conference 2020 on Monday, May 18, 2020. To access a live webcast of the Amedisys presentation, please log on through our website at http://investors.amedisys.com. Amedisys, Inc. is a leading healthcare at home company delivering personalized home health, hospice and personal care.
Amedisys, Inc. (AMED), a leading provider of home health, hospice and personal care, announced today that it has, through one of its wholly owned subsidiaries, signed a definitive agreement to acquire Homecare Preferred Choice, Inc., doing business as AseraCare Hospice (“AseraCare Hospice”), a national hospice care provider with an executive office in Plano, Texas and administrative support center in Fort Smith, Arkansas. Founded in 1994, AseraCare Hospice cares for more than 2,100 patients daily and employs more than 1,200 hospice professionals in 44 locations across 14 states, generating approximately $117 million in annual revenues. Under the terms of the agreement, expected to close on, or around, June 1, 2020, pending regulatory approvals, Amedisys will acquire 100 percent of the ownership interests in AseraCare Hospice for a cash purchase price of $235 million, which is inclusive of a $32 million tax asset bringing the net purchase price to $203 million.